Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Psychometric Evaluation of the Alcohol Use Disorders Identification Test and Short Drug Abuse Screening Test With Psychiatric Patients in India PDF $40.00
$40.00
× Placeholder Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence PDF $40.00
$40.00
× Placeholder Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF $40.00
$40.00
× Placeholder Catatonic Coma in a Patient With Schizophrenia Receiving Palliative Care With Reversal of Symptoms With Lorazepam PDF $40.00
$40.00
× Placeholder Efficacy of Topiramate in the Treatment of Crack Cocaine Dependence: A Double-Blind, Randomized, Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Psychopharmacologic Treatment of Posttraumatic Stress Disorder in Children and Adolescents: A Review PDF $40.00
$40.00
× Placeholder A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes PDF $40.00
$80.00
× Placeholder Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials PDF $40.00
$40.00
× Placeholder All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With Dementia: A Retrospective Cohort Study PDF $40.00
$40.00
× Placeholder A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder PDF $40.00
$40.00
× Placeholder A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression: A Decade of Clinical Follow-Up PDF $40.00
$40.00
× Placeholder Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study PDF $40.00
$40.00
× Placeholder Association Study of the 5-HTTLPR Polymorphism and Depression in 75-Year-Old Nondemented Subjects From the Vienna Transdanube Aging (VITA) Study PDF $40.00
$80.00
× Placeholder Underuse of Antidepressants in Major Depression: Prevalence and Correlates in a National Sample of Young Adults PDF $40.00
$40.00
× Placeholder Quantitative and Qualitative Analysis of the Quality of Life of Individuals With Eating Disorders PDF $40.00
$40.00
× Placeholder Electrocardiographic Abnormalities as Potential Contributors to Premature Mortality in Patients With Mental Illness in a Psychiatric Day Treatment Program PDF $40.00
$40.00
× Placeholder The Treatment of Chronic Depression, Part 2: A Double-Blind, Randomized Trial of Sertraline and Imipramine PDF $40.00
$40.00
× Placeholder BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study PDF $40.00
$40.00
× Placeholder Suspected Delirious Mania Lasting for Weeks After Urinary Tract Infection in an Elderly Woman With No Previous Psychiatric History PDF $40.00
$40.00
× Placeholder Prevalence and Severity of Intimate Partner Violence and Associations With Family Functioning and Alcohol Abuse in Psychiatric Inpatients With Suicidal Intent. PDF $40.00
$40.00
× Placeholder Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $960.00
Total $960.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe